FacebookTwitterGoogle+RedditEmail

Introducing Hil-A-Leve: the Pill that Specifically Targets Nausea Caused by the Clintons

It sounds like the very definition of “wonder drug:” just drop this little lime-green pill, and suddenly you can watch Hillary Clinton on the news without throwing up. Imagine: no nausea–even when she’s droppin’ her g’s for Southern audiences until she sounds like Larry the Cable Guy; promisin’ to “obliterate” Iran while claimin’ to care about children; pretendin’ she’s a champion of wimmin even though she stood by her man, Tammy Wynette-style, when he gutted funds for poor, single mothers.

If clinical trials hold true for the general public, this miracle drug, called Hil-A-Leve, may prove to be the biggest boon to mankind since penicillin.

In its early stages, Clinton Nausea Syndrome is marked by lethargy, cynicism, and projectile vomiting upon watching debates. If unchecked, CNS leads to an ever-deepening ennui, the severe clawing of one’s own skin, and–an especially heartbreaking symptom, because it only worsens the disease–an irrational compulsion to watch MSNBC. (See: Matz, DeGrom, Syndegaard, et al, in The Journal of Neo-Liberal “Psycho” Pharmacology.)

Victims also report a very rare form of dementia in which only one’s moral principles are forgotten. In its later stages, for example, the patient may show marked confusion about the TPP Treaty, and babble utterly contradictory opinions about the Keystone Pipeline. The final stages of CNS are hideous to behold. Victims are known to roll on the floor, compulsively repeating the words “glass ceiling, glass ceiling,” while being unable to remember the simple phrase “Glass-Stegall.”

CNS costs America millions of dollars each year in lost revenue, ravaging not just human bodies but the body politic itself.

The chemistry of Hil-A-Leve is fascinating. It’s a vaccine, synthesized from the blood of those who are, for unknown reasons, completely immune to Clinton Nausea Syndrome: Wall Street bankers, military contractors, and Anderson Cooper.

But if a Clinton-specific wonder drug seems too good to be true–it is. Here’s the bad news: a single Hil-A-Leve pill currently retails for $750–and Administration sources insist it will never be covered by Obamacare. So, to date, it’s only available to .01% percent of us. Still, its mere existence offers hope to the 3,000,000 potential victims in America alone, and billions more around the world–especially in Haiti, Venezuela, and the so-called “Arab countries.”

Caution: not yet proven effective against Debbie Wasserman-Schultz.

More articles by:

John Eskow is a writer and musician. He wrote or co-wrote the movies Air America, The Mask of Zorro, and Pink Cadillac, as well as the novel Smokestack Lightning. He is a contributor to Killing Trayvons: an Anthology of American Violence. He can be reached at: johneskow@yahoo.com

June 18, 2018
Paul Street
Denuclearize the United States? An Unthinkable Thought
John Pilger
Bring Julian Assange Home
Conn Hallinan
The Spanish Labyrinth
Patrick Cockburn
Attacking Hodeidah is a Deliberate Act of Cruelty by the Trump Administration
Gary Leupp
Trump Gives Bibi Whatever He Wants
Thomas Knapp
Child Abductions: A Conversation It’s Hard to Believe We’re Even Having
Robert Fisk
I Spoke to Palestinians Who Still Hold the Keys to Homes They Fled Decades Ago – Many are Still Determined to Return
Steve Early
Requiem for a Steelworker: Mon Valley Memories of Oil Can Eddie
Jim Scheff
Protect Our National Forests From an Increase in Logging
Adam Parsons
Reclaiming the UN’s Radical Vision of Global Economic Justice
Dean Baker
Manufacturing Production Falls in May and No One Notices
Laura Flanders
Bottom-Up Wins in Virginia’s Primaries
Binoy Kampmark
The Anguish for Lost Buildings: Embers and Death at the Victoria Park Hotel
Weekend Edition
June 15, 2018
Friday - Sunday
Dan Kovalik
The US & Nicaragua: a Case Study in Historical Amnesia & Blindness
Jeremy Kuzmarov
Yellow Journalism and the New Cold War
Charles Pierson
The Day the US Became an Empire
Jonathan Cook
How the Corporate Media Enslave Us to a World of Illusions
Ajamu Baraka
North Korea Issue is Not De-nuclearization But De-Colonization
Andrew Levine
Midterms Coming: Antinomy Ahead
Louisa Willcox
New Information on 2017 Yellowstone Grizzly Bear Deaths Should Nix Trophy Hunting in Core Habitat
Jeffrey St. Clair
Roaming Charges: Singapore Fling
Ron Jacobs
What’s So Bad About Peace, Man?
Robert Hunziker
State of the Climate – It’s Alarming!
L. Michael Hager
Acts and Omissions: The NYT’s Flawed Coverage of the Gaza Protest
Dave Lindorff
However Tenuous and Whatever His Motives, Trump’s Summit Agreement with Kim is Praiseworthy
Robert Fantina
Palestine, the United Nations and the Right of Return
Brian Cloughley
Sabre-Rattling With Russia
Chris Wright
To Be or Not to Be? That’s the Question
David Rosen
Why Do Establishment Feminists Hate Sex Workers?
Victor Grossman
A Key Congress in Leipzig
John Eskow
“It’s All Kinderspiel!” Trump, MSNBC, and the 24/7 Horseshit Roundelay
Paul Buhle
The Russians are Coming!
Joyce Nelson
The NED’s Useful Idiots
Lindsay Koshgarian
Trump’s Giving Diplomacy a Chance. His Critics Should, Too
Louis Proyect
American Nativism: From the Chinese Exclusion Act to Trump
Stan Malinowitz
On the Elections in Colombia
Camilo Mejia
Open Letter to Amnesty International on Nicaragua From a Former Amnesty International Prisoner of Conscience
David Krieger
An Assessment of the Trump-Kim Singapore Summit
Jonah Raskin
Cannabis in California: a Report From Sacramento
Josh Hoxie
Just How Rich Are the Ultra Rich?
CJ Hopkins
Awaiting the Putin-Nazi Apocalypse
Mona Younis
We’re the Wealthiest Country on Earth, But Over 40 Percent of Us Live in or Near Poverty
Dean Baker
Not Everything Trump Says on Trade is Wrong
James Munson
Trading Places: the Other 1% and the .001% Who Won’t Save Them
Rivera Sun
Stop Crony Capitalism: Protect the Net!
FacebookTwitterGoogle+RedditEmail